2008Zhongguo linchuang yaolixue yu zhiliaoxueRequires access

Clinical effects of combination therapy with sodium ozagrel and low molecular weight heparin on progressive cerebral infarction

Li Bin

Open publisher page 0 citations

Abstract

AIM:To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.METHODS:96 cases with acute progressive cerebral infarction were randomly divided into treatment group(48 cases)and control group(48 cases).The control group was only administered with 80 mg sodium ozagrel,bid,for 14 days.And the treatment group was administered with 80 mg sodium ozagrel,bid,for 14 days and 0.4 mL low molecular weight heparin sodium injection,bid,for 14 days.The number of platelet,blood clotting routine and the severity of neuro-functional defect(NDS)of both groups were detected before and after 14 days treatmeat.RESULTS:After 14 days treatment,the NDS of treatment group was significantly lower than that of control group(P0.05).The efficacy of treatment group was significantly better than that of control group(P0.05).Both the number of platelet and the blood coagulation time were in normal range.CONCLUSION:Sodium ozagrel combined with low molecular weight heparin sodium are an effective and safe therapy for progressive cerebral infarction.

About this research paper

What this paper is about

AIM:To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.METHODS:96 cases with acute progressive cerebral infarction were randomly divided into treatment group(48 cases)and control group(48 cases).The control group was only administered with 80 mg sodium ozagrel,bid,for 14 days.And the treatment group was administered with 80 mg sodium ozagrel,bid,for 14 days and 0.4 mL low molecular weight heparin sodium injection,bid,for 14 days.The number of platelet,blood clotting routine and the severity of neuro-functional defect(NDS)of both groups were detected before and after 14 days treatmeat.RESULTS:After 14 days treatment,the NDS of treatment group was significantly lower than that of control group(P0.05).The efficacy of treatment group was significantly better than that of control group(P0.05).Both the number of platelet and the blood coagulation time were in normal range.CONCLUSION:Sodium ozagrel combined with low molecular weight heparin sodium are an effective and safe therapy for progressive cerebral infarction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM:To observe the clinical effect of combination therapy with ozagrel and low molecular weight heparin on progressive cerebral infarction.METHODS:96 cases with acute progressive cerebral infarction were randomly divided into treatment group(48 cases)and control group(48 cases).The control group was only administered with 80 mg sodium ozagrel,bid,for 14 days.And the treatment group was administered with 80 mg sodium ozagrel,bid,for 14 days and 0.4 mL low molecular weight heparin sodium injection,bid,for 14 days.The number of platelet,blood clotting routine and the severity of neuro-functional defect(NDS)of both groups were detected before and after 14 days treatmeat.RESULTS:After 14 days treatment,the NDS of treatment group was significantly lower than that of control group(P0.05).The efficacy of treatment group was significantly better than that of control group(P0.05).Both the number of platelet and the blood coagulation time were in normal range.CONCLUSION:Sodium ozagrel combined with low molecular weight heparin sodium are an effective and safe therapy for progressive cerebral infarction.

Key concepts: Low molecular weight heparin, Cerebral infarction, Medicine, Anesthesia, Sodium, Heparin, Platelet, Heparin sodium

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical effects of combination therapy with sodium ozagrel and low molecular weight heparin on progressive cerebral infarction — Research Paper | ScholarLens